Chemed (NYSE:CHE) Hits New 1-Year Low - Time to Sell?

Chemed Co. (NYSE:CHE - Get Free Report) shares reached a new 52-week low during trading on Monday . The company traded as low as $524.50 and last traded at $524.50, with a volume of 60753 shares trading hands. The stock had previously closed at $531.68.

Chemed Price Performance

The firm has a market cap of $7.90 billion, a P/E ratio of 26.53, a PEG ratio of 2.19 and a beta of 0.46. The stock has a 50 day moving average of $585.30 and a 200 day moving average of $567.73.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same period in the previous year, the business earned $5.32 earnings per share. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. On average, research analysts predict that Chemed Co. will post 22.41 EPS for the current fiscal year.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now directly owns 103,735 shares in the company, valued at $62,117,555.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares of the company's stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at approximately $3,271,894.75. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,144 shares of company stock worth $3,002,419. Insiders own 3.32% of the company's stock.

Institutional Trading of Chemed

Hedge funds have recently made changes to their positions in the business. Thrivent Financial for Lutherans boosted its stake in shares of Chemed by 300.3% during the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company's stock valued at $63,249,000 after purchasing an additional 87,449 shares in the last quarter. International Assets Investment Management LLC purchased a new position in shares of Chemed in the third quarter worth $437,150,000. Impax Asset Management Group plc raised its holdings in shares of Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company's stock worth $172,510,000 after buying an additional 51,974 shares during the last quarter. ProShare Advisors LLC raised its holdings in shares of Chemed by 6,288.9% in the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company's stock worth $32,482,000 after buying an additional 49,808 shares during the last quarter. Finally, TD Asset Management Inc raised its holdings in shares of Chemed by 23.9% in the first quarter. TD Asset Management Inc now owns 254,953 shares of the company's stock worth $163,662,000 after buying an additional 49,176 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.